Many resources are needed to download a project. Please understand that we have to compensate our server costs. Thank you in advance. Project price only 1 $
You can buy this project and download/modify it how often you want.
{
"id" : "ss2018_mycosis_fungoides_94448",
"algorithm" : "eod_public",
"version" : "1.0",
"name" : "SS2018: Mycosis Fungoides",
"title" : "Summary Stage 2018: Mycosis Fungoides",
"subtitle" : "Summary Stage 2018",
"notes" : "**Mycosis Fungoides**\n\nC000 Vermilion border of upper lip (excludes external upper lip)\nC001 Vermilion border of lower lip (excludes external lower lip)\nC002 Vermilion border of lip, NOS (excludes external lip, NOS)\nC006 Commissure of lip\nC440 Skin of lip, NOS\nC441 Skin of eyelid \nC442 External ear \nC443 Skin of other and unspecified parts of face \nC444 Skin of scalp and neck\nC445 Skin of trunk \nC446 Skin of upper limb and shoulder \nC447 Skin of lower limb and hip \nC448 Overlapping lesion of skin\nC449 Skin, NOS\nC510 Labium majus\nC511 Labium minus\nC512 Clitoris\nC518 Overlapping lesion of vulva\nC519 Vulva, NOS\nC600 Prepuce\nC601 Glans penis\nC602 Body of penis\nC608 Overlapping lesion of penis\nC609 Penis\nC632 Scrotum, NOS\n\n**Note 1:** The following sources were used in the development of this schema\n* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)\n* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/)\n* Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx \n* Chapter 81 *Primary Cutaneous Lymphomas*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.\n\n**Note 2:** Code 0 is not applicable for this schema.\n\n**Note 3:** All lymph node (regional and distant) involvement is coded as regional lymph node involvement.\n\n**Note 4:** Visceral involvement is metastatic disease and should be questioned in the absence of node or blood involvement.",
"footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30\n\n(5) **Introduction to Hematologic Malignancies**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 931-935\n\n(6) Rosen, S.T., Jaffe, E.S., Leonard, J.P., et al. **Primary Cutaneous Lymphomas**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 967-972",
"last_modified" : "2018-03-12T16:39:56.979Z",
"definition" : [ {
"key" : "ss2018",
"name" : "SS2018",
"type" : "INPUT"
}, {
"key" : "description",
"name" : "Description",
"type" : "DESCRIPTION"
} ],
"rows" : [ [ "1", "Localized only (localized, NOS)\n- MFCG Stage I\n + Less than 10% of skin surface, no tumors\n + Limited to patches, papules, or plaques\n- MFCG Stage II\n + Greater than or equal to 10% of skin surface, no tumors\n + Generalized patches, papules, or plaques\n- Not stated whether patches, papules, or plaques\n + % of body surface not stated, no tumors\n + Skin involvement, NOS: extent not stated, no tumors" ], [ "2", "Regional by direct extension only\n- MFCG Stage III\n + Cutaneous tumor, size not stated\n + Generalized erythroderma (confluence of erythemia) \n * (greater than 50% of body involved with diffuse redness)\n + One or more tumors equal to 1 cm or greater\n + Sezary syndrome\n + Skin lesion described as tumor less than 1 cm" ], [ "3", "Regional lymph node(s) involved only\n- Both clinically enlarged palpable lymph node(s) (adenopathy) AND\n + pathologically positive nodes\n- Clinically enlarged palpable lymph node(s) (adenopathy) AND\n + either pathologically negative nodes or no pathological statement\n- No clinically enlarged palpable lymph node(s) (adenopathy) BUT\n + pathologically positive lymph node(s)\n- Dutch grade 1-4 OR NCI LN 0-4\n + Clone positive, negative or unknown\n- Regional lymph node(s), NOS\n + Lymph node(s), NOS" ], [ "4", "Regional by BOTH direct extension AND regional lymph node(s) involved\n- Codes (2) + (3)" ], [ "7", "Distant site(s) involved\n- Distant site(s) (including further contiguous extension)\n + MFCG Stage IV\n * Bone marrow\n * Involvement by at least one organ outside the skin, nodes, blood, or bone marrow\n * Liver\n * Spleen\n * Visceral (non-cutaneous, extranodal) involvement, pathologically confirmed\n- Distant metastasis, NOS \n + Carcinomatosis" ], [ "9", "Unknown if extension or metastasis" ] ]
}
